€ 27.5 million
$ 30.472 million
Announced
8/2/2019
Prin Shasiharan - Researcher
Belgium
United Kingdom
IPO
Capital markets : Equity
Pharmaceuticals and life sciences
Party: Kempen & Co (Joint global coordinator, Joint bookrunner)
Party: KBC Securities (Joint global coordinator, Joint bookrunner)
Party: Mirabaud Securities (Lead manager)